Phloroglucinol Biosynthesis via PhlD Enzyme
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing phloroglucinol and its derivative resorcinol rely on chemical organic synthesis using caustics and high temperatures, resulting in environmentally problematic waste and lack a fully biosynthetic route for commercial production.
Innovation Solution
A biosynthetic route for producing phloroglucinol from malonyl-CoA, using only the phlD enzyme or phloroglucinol synthase, which can convert malonyl-CoA into phloroglucinol, and subsequent hydrogenation to produce resorcinol, utilizing recombinant cells and enzymes capable of expressing the phlD gene.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical organic synthesis using caustics and high temperatures is used to produce phloroglucinol and resorcinol, then production efficiency is achieved, but environmentally problematic waste is generated
Solution Approach 1:
The patent replaces chemical synthesis mechanisms with biological enzymatic mechanisms. Specifically, it uses engineered microbial cells expressing phlD enzyme to catalyze the conversion of malonyl-CoA to phloroglucinol, substituting chemical reagents and high-temperature processes with biological catalysis that occurs under mild conditions, thereby eliminating caustic waste and reducing environmental impact while maintaining production efficiency
Solution Approach 2:
The patent changes the fundamental parameters of the synthesis process from chemical to biological conditions. The process operates at physiological temperatures (37°C), neutral pH, and atmospheric pressure instead of requiring caustics and high temperatures. This parameter transformation enables green chemistry principles while achieving commercial production levels through optimized fermentation processes
2Ease of manufacture
If multiple enzymes are used for biosynthetic production of phloroglucinol, then complete biosynthetic pathway is achieved, but process complexity increases
Solution Approach 1:
The patent extracts and utilizes only the essential phlD enzyme function from the complete phl operon system. By expressing solely the phlD gene in heterologous hosts, the invention accomplishes phloroglucinol production without requiring the other phl operon genes (phlA, phlB, phlC, phlE, phlF) that would be needed for complete acetylphloroglucinol biosynthesis, thereby simplifying the manufacturing process while achieving the desired biosynthetic outcome
Solution Approach 2:
Instead of following the natural acetylphloroglucinol biosynthetic pathway that requires multiple enzymes and produces acetylated derivatives, the patent inverts the approach by using phlD enzyme to directly produce phloroglucinol from malonyl-CoA. This reverse engineering strategy simplifies the pathway by eliminating the need for deacetylation steps and other auxiliary enzymes, achieving cleaner biosynthesis with fewer components
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a fully biosynthetic, anabolic route for phloroglucinol production, eliminating the need for multiple enzymes and reducing environmental impact, and allows for the efficient synthesis of phloroglucinol and its derivatives, including resorcinol, suitable for various applications such as medicaments, dyes, and adhesives.
Implementation Method 1
using only the phlD enzyme or phloroglucinol synthase, which can convert malonyl-CoA into phloroglucinol
Implementation Method 2
subsequent hydrogenation to produce resorcinol
Data Source
AI summary
The present invention provides methods, enzymes, and cells for the biosynthetic production of phloroglucinol from malonyl-CoA, which is ultimately obtained from simple starting materials such as glucose; also provided are methods for preparing derivatives of biosynthetic phloroglucinol, including, e.g., resorcinol.